Changes in glucose transport and protein kinase Cbeta(2) in rat skeletal muscle induced by hyperglycaemia

Diabetologia. 1999 Sep;42(9):1071-9. doi: 10.1007/s001250051273.

Abstract

Aims/hypothesis: We have previously reported that hyperglycaemia activates glucose transport in skeletal muscle by a Ca(2+)-dependent pathway, which is distinct from the insulin-signalling pathway. The aim of this study was to explain the signalling mechanism by which hyperglycaemia autoregulates glucose transport in skeletal muscle.

Methods: Isolated rat soleus muscle was incubated in the presence of various concentrations of glucose or 3-O-methylglucose and protein kinase C and phospholipase C inhibitors. Glucose transport activity, cell surface glucose transporter 1 and glucose transporter 4 content and protein kinase C translocation was determined.

Results: High concentrations of 3-O-methylglucose led to a concentration-dependent increase in [(3)H]-3-O-methylglucose transport in soleus muscle. Dantrolene, an inhibitor of Ca(2+) released from the sarcoplasmic reticulum, decreased the V(max) and the K(m) of the concentration-response curve. Protein kinase C inhibitors (H-7 and GF109203X) inhibited the stimulatory effect of high glucose concentrations on hexose transport, whereas glucose transport stimulated by insulin was unchanged. Incubation of muscle with glucose (25 mmol/l) and 3-O-methylglucose (25 mmol/l) led to a three fold gain in protein kinase Cbeta(2) in the total membrane fraction, whereas membrane content of protein kinase Calpha, beta(1), delta, epsilon and theta were unchanged. A short-term increase in the extracellular glucose concentration did not change cell surface recruitment of glucose transporter 1 or glucose transporter 4, as assessed by exofacial photolabelling with [(3)H]-ATB-BMPA bis-mannose.

Conclusion/interpretation: Protein kinase Cbeta(2) is involved in a glucose-sensitive, Ca(2+)-dependent signalling pathway, which is possibly involved in the regulation of glucose transport in skeletal muscle. This glucose-dependent increase in 3-0-methylglucose transport is independent of glucose transporter 4 and glucose transporter 1 translocation to the plasma membrane and may involve modifications of cell surface glucose transporter activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-O-Methylglucose / metabolism*
  • Animals
  • Cell Membrane / metabolism
  • Glucose / metabolism*
  • Glucose / pharmacology
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Hyperglycemia / metabolism*
  • In Vitro Techniques
  • Insulin / pharmacology
  • Isoenzymes / metabolism*
  • Kinetics
  • Male
  • Monosaccharide Transport Proteins / metabolism*
  • Muscle Proteins*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism*
  • Protein Kinase C / metabolism*
  • Protein Kinase C beta
  • Rats
  • Rats, Wistar

Substances

  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Insulin
  • Isoenzymes
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • Slc2a1 protein, rat
  • Slc2a4 protein, rat
  • 3-O-Methylglucose
  • Protein Kinase C
  • Protein Kinase C beta
  • Glucose